Global Metabolomics Market is Expected to Get US$ 2 Billion By 2024

The global metabolomics market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 45% of the metabolomics market in 2014. The market in Asia Pacific is projected to grow at a CAGR of 24% during the forecast period. Increasing penetration of pharmaceutical products is stimulating the growth of the market in Asia Pacific. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Russia, Brazil, and GCC countries. The report includes a detailed study of the global and regional metabolomics market and analyzes the variations in the growth of the industry in certain regions.

The global metabolomics market is expected to reach US$ 2 billion by 2024, registering a compound annual growth rate (CAGR) of 17.10% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/metabolomics-market

The growing demand for personalized medicine, increasing use of metabolomics in toxicology testing, and availability of government and private funding are driving the market. In addition, the increasing R&D expenditure on pharmaceutical and biotech and technological advancements are expected to fuel the growth of the market. However, the issues related to data examination and processing and the high cost of tools and instruments are hampering the growth of the market.

Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, Agilent Technologies, Metabolon, Inc., Shimadzu Corporation, Bruker Corporation, and Biocrates Life Sciences AG are the most active Key players in the metabolomics market.

The major driving factors of metabolomics market are as follows:

o Rising research funding and administration support drives the market growth.
o Use in biotechnology and pharmaceutical area spur the metabolomics research.
o Growing requirement of personalized medication within healthcare industry.
o Increasing requirement for toxicity equipment.

The restraints factors of metabolomics market are as follows:

o Data examination and data processing.
o Low acceptance rate.

In this report, the global metabolomics market is segmented by technique, application, indication, and region. On the basis of technique, the market is segmented into separation techniques, such as gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra performance liquid chromatography; and detection techniques, such as nuclear magnetic resonance spectroscopy, mass spectrometry, and surface based mass analysis. The market on the basis of application is segmented into biomarker discovery, drug discovery/drug assessment toxicology testing, nutrigenomics, and others. The market by indication is segmented into oncology, neurology, cardiology, and others.

Request Free Sample Report: https://www.marketresearchengine.com/reportdetails/metabolomics-market

This report covers the metabolomics market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Availability of Government and Private Funding
5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
5.2.1.3 Technological Advancements
5.2.1.4 Growing Demand for Personalized Medicine
5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
5.2.2 Key Market Restraints
5.2.2.1 Issues Related to Data Examination and Processing
5.2.2.2 High Cost of Tools and Instruments
5.2.3 Key Market Opportunities
5.2.3.1 Biomarker Development
5.2.3.2 Rapid Growth Opportunities in Emerging Markets
5.2.4 Key Challenges
5.2.4.1 Complexity and Diversity of Biological Samples
5.2.4.2 Dearth of Skilled Researchers
6 Industry Insights
7 Technology Investment Potential
8 Global Metabolomics Market, By Product and Service
9 Global Metabolomics Market, By Application
10 Global Metabolomics Market, By Indication
11 Global Metabolomics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.1 Introduction
13.2 Thermo Fisher Scientific Inc.
13.3 Agilent Technologies, Inc.
13.4 Waters Corporation
13.5 Danaher Corporation
13.6 Shimadzu Corporation
13.7 Biocrates Life Sciences AG
13.8 Bio-Rad Laboratories, Inc.
13.9 Bruker Corporation
13.10 Human Metabolome Technologies, Inc.
13.11 Leco Corporation
13.12 Metabolon, Inc.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.